| Friday, 25 September 2026 | ||
|---|---|---|
| 13:30-14:00 | Opening & Introduction | |
| 13:30-13:40 | Welcome Speech by Organizing Committee | Serkan Özben, Murat Terzi |
| 13:40-14:00 | Opening Keynote | Jelena Drulović |
| 14:00-15:10 | Session 1: Early and Prodromal Parkinson's Disease | |
| Chairs: Ayşe Bora Tokçaer, Raif Çakmur, Serkan Özben | ||
| 14:00-14:20 | Parkinson’s Disease: Molecular Pathology, Clinical Implications and Recent Advances | Bülent Elibol |
| 14:20-14:40 | Differential Diagnosis in Parkinsonism | Serhat Özkan |
| 14:40-15:00 | Non-motor symptoms in Parkinson disease-Impact on the disease course and treatment | Nataša Dragašević |
| 15:00-15:10 | Questions & Answers | |
| 15:10-15:30 | COFFEE BREAK | |
| 15:30-16:55 | Session 2: Advanced and Device-Aided Therapies in Parkinson's Disease | |
| Chairs: Dimitar Maslarov, Nataša Dragašević, Okan Doğu | ||
| 15:30-15:45 | Infusion Therapies: Where Do We Stand in 2026? | Nevena Kamenova |
| 15:45-16:00 | Deep Brain Stimulation in Parkinson's Disease: Patient Selection and Long-Term Outcomes | Gençer Genç |
| 16:00-16:15 | Deep Brain Stimulation in Dystonia | Vladana Marković |
| 16:15-16:30 | The Next Frontier in Parkinson’s Interventions: From Natural History to AI-Driven Adaptive Neuromodulation | Dimitar Maslarov |
| 16:30-16:45 | Impulse Control Disorders in Parkinson's Disease: Clinical Implications and Management Strategies | Igor Petrović |
| 16:45-16:55 | Questions & Answers | |
| 16:55-17:35 | Session 3: Parkinson's Disease: Panel Discussion & Rapid-Fire Questions | |
| Chairs: Bülent Elibol, Igor Petrović, Ivan Milanov | Panelists: | |
| Moderator: Bülent Elibol | Andona Milovanović Ayşegül Gündüz Desislava Bogdanova Gençer Genç Haşmet Hanağası Maksim Šarčević Nina Mazalica |
|
| Session Fellows: Ahmet Onur Keskin, Gözde Ünal | ||
| 17:35-18:35 | Abstract Sessions: Oral Presentations | |
| Chairs: Sibel Canbaz Kabay, Şeyda Figül Gökçe | Hall 1 | |
| Abstract Sessions: Poster Presentations | ||
| Chairs:Ufuk Emre Toprak, Yusuf Tamam | Foyer | |
| Saturday, 26 September 2026 | ||
|---|---|---|
| 08:30-09:20 | Breakfast with the Professors | |
Hüsnü Efendi - Šarlota Mesaroš - Nilüfer Kale İçen - Jasna Jančić - Aslı Aksoy Gündoğdu - Gökçen Gözübatık Çelik - Özlem Ethemoğlu - Rabia Koç |
||
Bülent Elibol - Enra Mehmedica Suljić - Liljana Radulović - Evica Dinčić- Lorand Sakalas - Marko Andabaka - Ayça Gül Güngördü - Haluk Gümüş |
||
Ayşe Altıntaş - Tatjana Bošković Matić - Ivan Milanov - Nikola Momčilović - Aleksandar Pantović - Sedat Şen - Meral Seferoğlu - Coşkun Kerala |
||
Jelena Drulović - Rana Karabudak - Tatjana Petkovska Boshkova - Dejan Aleksić - Marta Jeremić - Dr. Hamza Jatić - Mehmet Fatih Yetkin- Sami Ömer Hoca |
||
| 09:30-10:40 | Session 4: Redefining Alzheimer's Disease: From Biology to Clinical Practice | |
| Chairs: Haşmet Hanağası, Latchezar Traykov, Tanja Stojković | ||
| 09:30-09:50 | Is Alzheimer’s a Clinical Syndrome or a Biological Entity? | Elka Stefanova |
| 09:50-10:10 | Blood-Based Biomarkers in Early Alzheimer's Disease: Where Do We Stand in 2026? | Başar Bilgiç |
| 10:10-10:30 | Novel and future treatments of Alzheimer's disease | Haşmet Hanağası |
| 10:30-10:40 | Questions & Answers | |
| 10:40-11:00 | COFFEE BREAK | |
| 11:00-12:10 | Session 5: Preventing Alzheimer's Disease: From Risk Reduction to Early Intervention | |
| Chairs: Elka Stefanova, Esen Saka Topçuoğlu, Shima Mehrabian | ||
| 11:00-11:15 | Prevention Strategies in Alzheimer's Disease: Lifestyle, Pharmacology, and Combination Approaches | Tanja Stojković |
| 11:15-11:30 | Malnutrition in Dementia and Other Neurodegenerative Disorders | Nazlı Durmaz Çelik |
| 11:30-11:45 | Artificial Intelligence in Alzheimer's Disease: From Early Detection to Treatment Monitoring | Erdi Şahin |
| 11:45-12:00 | Risks, Benefits and Challenges of Early Detection for Pre-Dementia Alzheimer's Disease | Shima Mehrabian |
| 12:00-12:10 | Questions & Answers | |
| 12:10-12:40 | Session 6: Alzheimer's Disease: Panel Discussion & Rapid-Fire Questions | |
| Chairs: Başar Bilgiç, Elka Stefanova, Latchezar Traykov | Panelists: | |
| Moderator: Başar Bilgiç Session Fellows: Esra Acıman, Zeynep Özözen Ayas |
Erdi Şahin Gorana Mandić Nazlı Durmaz Çelik Shima Mehrabian Tanja Stojkovć |
|
| 12:40-13:50 | LUNCH BREAK | |
| 13:50-14:30 | INDUSTRY SUPPORTED SESSION | |
| 14:30-16:00 | Session 7: Brain Health in Multiple Sclerosis: From Care Models to Long-Term Outcomes | |
| Chairs: Hüsnü Efendi, Mesrure Köseoğlu, Uğur Uygunoğlu | ||
| 14:30-14:50 | Importance of MS units in Neurology Department | Jelena Drulović |
| 14:50-15:10 | Unveiling PIRA: The Silent Driver of Neurodegeneration in Multiple Sclerosis | Murat Kürtüncü |
| 15:10-15:30 | An overview: How changing immunological paradigms impacted our current treatment approaches | Rana Karabudak |
| 15:30-15:50 | Where Does IVIg Fit in the Era of Targeted Immunotherapies? | Arman Çakar |
| 15:50-16:00 | Questions & Answers | |
| 16:00-16:20 | COFFEE BREAK | |
| 16:20-17:40 | Session 8:Preventing Neurodegeneration in MS: Clinical Decisions in the High-Efficacy Era | |
| Chairs: Aysun Ünal, Tatjana Petkovska Boskova, Yeşim Beckman | ||
| 16:20-16:40 | Neurodegenerative Mechanisms in Immune-Mediated CNS Disorders | Erdem Tüzün |
| 16:40-17:00 | Pediatric-Onset MS: Preserving Brain Reserve from Disease Onset | Paulina Ilieva |
| Late-Onset MS: Aging, Neurodegeneration and Therapeutic Challenges | Mihaela Sergeeva | |
| 17:00-17:20 | Escalation, Switching and Disease Control in Modern MS Care | Sonya Ivanova |
| De-escalation and Treatment Discontinuation: Protecting Brain Health in Aging MS | Šarlota Mesaroš | |
| 17:20-17:30 | Social Value of Early High-Effcacy Treatments | Serkan Demir |
| 17:30-17:40 | Questions & Answers | |
| 17:40-18:10 | Session 9: Multiple Sclerosis: Panel Discussion & Rapid-Fire Questions | |
| Chairs: Ljiljana Radulović, Rana Karabudak, Slobodan Vojinović | Panelists | |
| Moderator: Aslı Tuncer Session Fellows: Mehmet Demir, Keriman Oğuz |
Cihat Uzunköprü Maja Budimkić Olivera Tamaš Sonya Ivanova Tuncay Gündüz Vesna Suknjaja |
|
| Sunday, 27 September 2026 | ||
|---|---|---|
| 09:00-10:00 | Abstract Sessions: Oral Presentations | |
| Chairs: Bengü Altunan, Mehmet Demir | Hall 1 | |
| 09:00-10:00 | Abstract Sessions: Poster Presentations | |
| Chairs: Tahir Kurtuluş Yoldaş, Ufuk Aluçlu | Foyer | |
| Chairs: Saltanat Mert, Zeynep Özdemir | Foyer | |
| 10:00-11:10 | Session 10: Autoimmune Demyelinating Diseases: Biomarkers, Disability Prevention and Precision Therapies | |
| Chairs: Ayşe Altıntaş, Šarlota Mesaroš | ||
| 10:00-10:20 | NMOSD vs MOGAD: Distinguishing Phenotypes and Biomarkers in Clinical Practice | Ivan Milanov |
| 10:20-10:40 | Precision Treatment in NMOSD: Matching the Right Therapy to the Right Patient | Nikola Veselinović |
| 10:40-11:00: | Vaccination Strategies in Patients Receiving Targeted Immunotherapies | Tatjana Pekmezović |
| 11:00-11:10 | Questions & Answers | |
| 11:10-12:40 | Session 11: Motor Neuron Diseases: From Genetics to Disease Modification | |
| Chairs: Aleksa Palibrk, Zorica Stević | ||
| 11:10-11:30 | ALS Genetics: From Risk Genes to Precision Medicine | Ana Marjanović |
| 11:30-11:50 | ALS Motor Phenotypes: Upper vs Lower Motor Neuron Involvement and New Classification | Zorica Stević |
| 11:50-12:10 | Diagnostic Strategies and Treatment Options in ALS | Sezin Alpaydın Baslo |
| 12:10-12:30 | SMA in the Treatment Era: Long-Term Outcomes and New Challenges | Nataša Cerovac |
| 12:30-12:40 | Questions & Answers | |
| 12:40-13:00 | Closing Remarks & Future Collaborations | |
| Closing Speech by Organizing Committee | Aysun Ünal Mesrure Köseoğlu Serkan Özben |
|